← Back to Search

Common Elements Toolbox for Depression

N/A
Waitlist Available
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between 13 and 20 years old and a student at a participating Greek high school. Access to the internet
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the intervention
Awards & highlights

Study Summary

This trial will test whether the COMET intervention leads to reductions in depressive symptoms, anxiety symptoms, and subjective well-being in adolescents, compared to an active control condition. The trial will also examine whether the intervention is more effective for those who report elevated symptoms at baseline.

Eligible Conditions
  • Depression
  • Anxiety
  • Happiness

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 weeks post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 weeks post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anti-Anxiety Agents
Change in Patient Health Questionnaire-8 (PHQ-8)
Change in the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS)
Secondary outcome measures
Perceived Utility
Positive and Negative Affect Schedule (PANAS)
Ratings on the Acceptability of Intervention Measure (AIM)
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Common Elements Toolbox (COMET)Experimental Treatment1 Intervention
Group II: Active Control ConditionActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Common Elements Toolbox
2020
N/A
~520

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,002 Previous Clinical Trials
42,880,599 Total Patients Enrolled
68 Trials studying Depression
29,008 Patients Enrolled for Depression
National and Kapodistrian University of Athens, GreeceUNKNOWN
1 Previous Clinical Trials
500 Total Patients Enrolled
University Mental Health, Neurosciences and Precision Medicine Research Institute "Costas Stefanis," GreeceUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial extend to adults over the age of thirty?

"This study is accepting participants who are between 13 and 20 years of age."

Answered by AI

What is the objective of this experiment?

"This medical trial, which spans a period of 4 weeks post-intervention, aims to measure changes in Generalized Anxiety Disorder Screener-7 (GAD-7) scores. Secondary outcomes include an assessment of participants' secondary control, their perceived utility and ratings on the Intervention Appropriateness Measure (IAM)."

Answered by AI

Is this test currently open to new participants?

"As confirmed by clinicaltrials.gov, this trial is actively recruiting volunteers; the first posting was on March 22nd 2021 and it has been amended as recently as October 18th 2021."

Answered by AI

What prerequisites do participants need to fulfill in order to qualify for the clinical trial?

"To be enrolled in this trial, participants must have a contentment rating of 10/10 and age-range anywhere from 13 to 20 years old. A total of 400 individuals will be accepted into the study."

Answered by AI

How many participants are engaged in this research project?

"Affirmative. Per the information on clinicaltrials.gov, this medical study is currently accepting applicants. This trial was initially posted on March 22nd 2021 and last modified October 18th 2021; 400 participants are needed from a single location for the research to be successful."

Answered by AI
~98 spots leftby Apr 2025